Difference between revisions of "Journal Club"
From Bioinformatics Lab
Line 1: | Line 1: | ||
+ | {|class=wikitable style="text-align:center;" | ||
+ | |+style="text-align:left;font-size:12pt" | 2021-1st semester | ||
+ | |- | ||
+ | !scope="col" style="padding:.4em" |Date | ||
+ | !scope="col" stype="padding:.4em" | Team | ||
+ | !scope="col" style="padding:.4em" | Paper<br/>index | ||
+ | !scope="col" style="padding:.4em" | Presenter | ||
+ | !scope="col" style="padding:.4em" | Paper title | ||
+ | |- | ||
+ | |style="padding:.4em;" rowspan=3|2022 | ||
+ | |style="padding:.4em;" rowspan=3|- | ||
+ | |style="padding:.4em;"|21-27 | ||
+ | |style="padding:.4em;"| | ||
+ | |style="padding:.4em;text-align:left"| | ||
+ | [https://www.sciencedirect.com/science/article/pii/S1931312820306193 Automated Prediction and Annotation of Small Open Reading Frames in Microbial Genomes] | ||
+ | |- | ||
+ | |||
+ | |style="padding:.4em;"|21-26 | ||
+ | |style="padding:.4em;"| | ||
+ | |style="padding:.4em;text-align:left"| | ||
+ | [https://www.sciencedirect.com/science/article/pii/S1931312820305734 Identification of Natural CRISPR Systems and Targets in the Human Microbiome] | ||
+ | |- | ||
+ | |||
+ | |style="padding:.4em;"|21-25 | ||
+ | |style="padding:.4em;"| | ||
+ | |style="padding:.4em;text-align:left"| | ||
+ | [https://www.sciencedirect.com/science/article/pii/S0092867421000726 Massive expansion of human gut bacteriophage diversity] | ||
+ | |- | ||
+ | |style="padding:.4em;" rowspan=2|2022 | ||
+ | |style="padding:.4em;" rowspan=2|- | ||
+ | |style="padding:.4em;"|21-24 | ||
+ | |style="padding:.4em;"| | ||
+ | |style="padding:.4em;text-align:left"| | ||
+ | [https://science.sciencemag.org/content/366/6471/eaax9176 A metagenomic strategy for harnessing the chemical repertoire of the human microbiome] | ||
+ | |- | ||
+ | |style="padding:.4em;"|21-23 | ||
+ | |style="padding:.4em;"| | ||
+ | |style="padding:.4em;text-align:left"| | ||
+ | [https://www.nature.com/articles/s41467-019-10927-1 Predictive metabolomic profiling of microbial communities using amplicon or metagenomic sequences] | ||
+ | |- | ||
+ | |style="padding:.4em;" rowspan=2|2022 | ||
+ | |style="padding:.4em;" rowspan=2|- | ||
+ | |style="padding:.4em;"|21-22 | ||
+ | |style="padding:.4em;"| | ||
+ | |style="padding:.4em;text-align:left"| | ||
+ | [https://www.nature.com/articles/s41564-018-0306-4 Gut microbiome structure and metabolic activity in inflammatory bowel disease] | ||
+ | |- | ||
+ | |style="padding:.4em;"|21-21 | ||
+ | |style="padding:.4em;"| | ||
+ | |style="padding:.4em;text-align:left"| | ||
+ | [https://www.nature.com/articles/s41591-020-01183-8 Microbiome connections with host metabolism and habitual diet from 1,098 deeply phenotyped individuals] | ||
+ | |- | ||
+ | |style="padding:.4em;" rowspan=2|2022 | ||
+ | |style="padding:.4em;" rowspan=2|- | ||
+ | |style="padding:.4em;"|21-20 | ||
+ | |style="padding:.4em;"| | ||
+ | |style="padding:.4em;text-align:left"| | ||
+ | [https://www.nature.com/articles/s41467-020-18476-8 A predictive index for health status using species-level gut microbiome profiling] | ||
+ | |- | ||
+ | |style="padding:.4em;"|21-19 | ||
+ | |style="padding:.4em;"| | ||
+ | |style="padding:.4em;text-align:left"| | ||
+ | [https://www.nature.com/articles/s41586-019-1237-9 Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases] | ||
+ | |- | ||
+ | |style="padding:.4em;" rowspan=2|2022 | ||
+ | |style="padding:.4em;" rowspan=2|- | ||
+ | |style="padding:.4em;"|21-18 | ||
+ | |style="padding:.4em;"| | ||
+ | |style="padding:.4em;text-align:left"| | ||
+ | [https://www.nature.com/articles/s41467-021-21475-y Gastrointestinal microbiota composition predicts peripheral inflammatory state during treatment of human tuberculosis] | ||
+ | |- | ||
+ | |style="padding:.4em;"|21-17 | ||
+ | |style="padding:.4em;"| | ||
+ | |style="padding:.4em;text-align:left"| | ||
+ | [https://www.sciencedirect.com/science/article/pii/S1931312820301694 Structure of the Mucosal and Stool Microbiome in Lynch Syndrome] | ||
+ | |- | ||
+ | |style="padding:.4em;" rowspan=2|2022 | ||
+ | |style="padding:.4em;" rowspan=2|- | ||
+ | |style="padding:.4em;"|21-16 | ||
+ | |style="padding:.4em;"| | ||
+ | |style="padding:.4em;text-align:left"| | ||
+ | [https://science.sciencemag.org/content/369/6506/936 Cross-reactivity between tumor MHC class 1-restricted antigens and an enterococcal bacteriophage] | ||
+ | |- | ||
+ | |style="padding:.4em;"|21-15 | ||
+ | |style="padding:.4em;"| | ||
+ | |style="padding:.4em;text-align:left"| | ||
+ | [https://www.nature.com/articles/s41564-020-00831-6 Bifidobacterium bifidum strains synergize with immune checkpoint inhibitors to reduce tumour burden in mice] | ||
+ | |- | ||
+ | |style="padding:.4em;" rowspan=2|2022 | ||
+ | |style="padding:.4em;" rowspan=2|- | ||
+ | |style="padding:.4em;"|21-14 | ||
+ | |style="padding:.4em;"| | ||
+ | |style="padding:.4em;text-align:left"| | ||
+ | [https://www.nature.com/articles/s41591-020-01223-3 The gut microbiome modulates the protective association between a Mediterranean diet and cardiometabolic disease risk] | ||
+ | |- | ||
+ | |style="padding:.4em;"|21-13 | ||
+ | |style="padding:.4em;"| | ||
+ | |style="padding:.4em;text-align:left"| | ||
+ | [https://www.nature.com/articles/s41467-019-14177-z Impact of commonly used drugs on the composition and metabolic function of the gut microbiota] | ||
+ | |- | ||
+ | |style="padding:.4em;" rowspan=2|2022 | ||
+ | |style="padding:.4em;" rowspan=2|- | ||
+ | |style="padding:.4em;"|21-12 | ||
+ | |style="padding:.4em;"| | ||
+ | |style="padding:.4em;text-align:left"| | ||
+ | [https://www.sciencedirect.com/science/article/pii/S0092867420305638 Personalized Mapping of Drug Metabolism by the Human Gut Microbiome] | ||
+ | |- | ||
+ | |style="padding:.4em;"|21-11 | ||
+ | |style="padding:.4em;"| | ||
+ | |style="padding:.4em;text-align:left"| | ||
+ | [https://www.cell.com/fulltext/S0092-8674(17)30107-1 Mining the Human Gut Microbiota for Immunomodulatory Organisms] | ||
+ | |- | ||
+ | |style="padding:.4em;" rowspan=2|2022 | ||
+ | |style="padding:.4em;" rowspan=2|- | ||
+ | |style="padding:.4em;"|21-10 | ||
+ | |style="padding:.4em;"| | ||
+ | |style="padding:.4em;text-align:left"| | ||
+ | [https://www.nature.com/articles/s41586-020-2095-1 Microbiome analyses of blood and tissues suggest cancer diagnostic approach] | ||
+ | |- | ||
+ | |style="padding:.4em;"|21-9 | ||
+ | |style="padding:.4em;"| | ||
+ | |style="padding:.4em;text-align:left"| | ||
+ | [https://science.sciencemag.org/content/368/6494/973 The human tumor microbiome is composed of tumor type-specific intracellular bacteria] | ||
+ | |} | ||
+ | |||
{|class=wikitable style="text-align:center;" | {|class=wikitable style="text-align:center;" | ||
|+style="text-align:left;font-size:12pt" | 2021 | |+style="text-align:left;font-size:12pt" | 2021 |
Revision as of 14:41, 4 March 2021
Date | Team | Paper index |
Presenter | Paper title |
---|---|---|---|---|
2021/02/22 | Single-cell | 21-8 | IS Choi |
Functional CRISPR dissection of gene networks controlling human regulatory T cell identity |
21-7 | JH Cha |
Molecular Pathways of Colon Inflammation Induced by Cancer Immunotherapy | ||
2021/02/15 | Single-cell | 21-6 | SB Baek | |
21-5 | IS Choi |
Trajectory-based differential expression analysis for single-cell sequencing data | ||
2021/02/08 | Single-cell | 21-4 | SB Baek |
Genetic determinants of co-accessible chromatin regions in activated T cells across humans |
21-3 | JH Cha |
Single-Cell Analyses Inform Mechanisms of Myeloid-Targeted Therapies in Colon Cancer | ||
2021/02/01 | Single-cell | 21-2 | JW Cho | |
21-1 | JW Cho |